Skip to main content
. 2016 Jan 4;6:18642. doi: 10.1038/srep18642

Figure 6. Galangin sensitizes human renal carcinoma cells, but not normal cells to TRAIL-mediate apoptosis.

Figure 6

ACHN cells (a) and A498 cells (b) were treated with 30 μM galangin with or without 50 ng/ml TRAIL for 24 h. The sub G1 population was measured by flow cytometry. The protein levels of PARP were determined by western blot analysis. (cropped, full-length blots are in Supplementary Fig. S9). (c,d) Caki, TMCK-1 and mesangial cells (MC) were treated with 50 ng/ml TRAIL with or without 30 μM galangin for 24 h. The morphology of cells was represented using interference light microscopy (c). (d) The sub G1 population was measured by flow cytometry.